EMAIL THIS PAGE TO A FRIEND

Bioorganic & medicinal chemistry letters

SAR and inhibitor complex structure determination of a novel class of potent and specific Aurora kinase inhibitors.


PMID 16337122

Abstract

A novel series of 5-aminopyrimidinyl quinazolines has been developed from anilino-quinazoline 1, which was identified in a high throughput screen for Aurora A. Introduction of the pyrimidine ring and optimisation of the substituents both on this ring and at the C7 position of the quinazoline led to the discovery of compounds that are highly specific Aurora kinase inhibitors. Co-crystallisation of one of these inhibitors with a fragment of Aurora A shows the importance of the benzamido group in achieving selectivity.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

D6068
N-[4-[(6,7-Dimethoxy-4-quinazolinyl)amino]phenyl]benzamide hydrochloride, ≥98% (HPLC), solid
C23H20N4O3 · HCl